作者: G. M. Daragan , T. Yu. Krushinska , D. O. Stepanskiy , I. V. Demchyshyna , I. P. Kolesnikova
DOI: 10.26641/2307-0404.2018.1(PART1).127206
关键词: Measles virus 、 Measles 、 Epidemiological surveillance 、 Rubella 、 National laboratory 、 Transmission (medicine) 、 Environmental health 、 Vaccination 、 Preventive vaccination 、 Medicine
摘要: The analysis of measles and rubella morbidity, the state their vaccination in Ukraine was carried out. Despite decades preventive vaccination, there is a 5-6 years’ cyclicity epidemic process at present time. Measles morbidity increased 46.8 times 2017 comparison with 2016. Elevated rates were registered 2004 2011. There decrease routine immunization coverage period from 2009 to Critically low noted 2016 – 45.5% (vaccination) 30.2% (revaccination). In spite progress (93.3% 90.7% revaccination), has not achieved (≥95.0%) necessary interrupt these pathogens circulation. national laboratory network regional ones, in-system Global Rubella Laboratory Network, established ensure high-quality performance epidemiological surveillance. Genotyping clinical samples Ukrainian patients out WHO Regional Reference (Luxembourg). Different genetic lines virus prevalence D8 genotype indicated circulate Ukraine. B3 also identified D9 isolated for first furtherance goal elimination Ukraine, standard international approaches clinical, epidemiological diagnosis cases, investigation viruses transmission chains detection endemicity cases are course implementation. Quality executing activities assessed according relevant indicators.